Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-08 Sale |
2022-06-09 7:47 pm |
NeuroPace Inc | NPCE | Ridley Irina General Counsel and Secretary |
2,500 | $5.778 | $14,445 | 61,139 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-01 7:35 pm |
NeuroPace Inc | NPCE | Ridley Irina General Counsel and Secretary |
1,470 | $7.5386 | $11,082 | 6,652 (Direct) |
View |
| 2021-04-21 Purchase |
2021-04-23 8:32 pm |
NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
235,000 | $17 | $3,995,000 | 235,000 (Indirect) |
View |
| 2021-04-21 Purchase |
2021-04-23 7:58 pm |
NeuroPace Inc | NPCE | Ridley Irina General Counsel and Secretary |
2,352 | $17 | $39,984 | 2,352 (Direct) |
View |
| 2021-04-21 Purchase |
2021-04-23 7:44 pm |
NeuroPace Inc | NPCE | Accelmed Partners II L.P. 10% Owner |
588,235 | $17 | $9,999,995 | 588,235 (Direct) |
View |
| 2021-04-21 Purchase |
2021-04-23 7:43 pm |
NeuroPace Inc | NPCE | Fischer Frank M Director |
50,000 | $17 | $850,000 | 114,989 (Direct) |
View |
| 2021-04-21 Purchase |
2021-04-23 7:27 pm |
NeuroPace Inc | NPCE | Garfield Greg Shaw Director |
13,235 | $17 | $224,995 | 60,551 (Direct) |
View |
| 2021-04-21 Purchase |
2021-04-23 7:26 pm |
NeuroPace Inc | NPCE | Norton Evan Director |
588,235 | $17 | $9,999,995 | 588,235 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-13 Option Award |
2022-06-21 9:12 pm |
N/A 2032-06-12 |
NeuroPace Inc | NPCE | Fischer Frank M Director |
18,253 | $0 | 18,253 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-21 9:12 pm |
N/A 2032-06-12 |
NeuroPace Inc | NPCE | Garfield Greg Shaw Director |
18,253 | $0 | 18,253 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-21 9:11 pm |
N/A 2032-06-12 |
NeuroPace Inc | NPCE | Kumar Rakhi Director |
18,253 | $0 | 18,253 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-21 9:10 pm |
N/A 2032-06-12 |
NeuroPace Inc | NPCE | LACOB JOSEPH Director |
18,253 | $0 | 18,253 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-21 9:09 pm |
N/A 2032-06-12 |
NeuroPace Inc | NPCE | Ryan Renee Director |
18,253 | $0 | 18,253 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-08 4:43 pm |
2022-03-08 2032-03-07 |
NeuroPace Inc | NPCE | Favet Michael Chief Executive Officer |
465,240 | $0 | 492,240 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:07 pm |
2022-03-03 2032-03-02 |
NeuroPace Inc | NPCE | Ridley Irina General Counsel and Secretary |
140,517 | $0 | 147,169 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:06 pm |
2022-03-03 2032-03-02 |
NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer |
140,220 | $0 | 151,756 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:06 pm |
2022-03-03 2032-03-02 |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
140,290 | $0 | 150,118 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-02 8:49 pm |
N/A 2031-10-31 |
NeuroPace Inc | NPCE | Andrade Lisa Director |
11,836 | $0 | 11,836 (Direct) |
View |
| 2021-04-21 Option Award |
2021-10-08 6:18 pm |
N/A 2031-04-20 |
NeuroPace Inc | NPCE | Ryan Renee Director |
21,698 | $0 | 21,698 (Direct) |
View |
| 2021-04-21 Option Award |
2021-10-08 6:17 pm |
N/A 2031-04-20 |
NeuroPace Inc | NPCE | Norton Evan Director |
21,698 | $0 | 21,698 (Direct) |
View |
| 2021-04-21 Option Award |
2021-10-08 6:16 pm |
N/A 2031-04-20 |
NeuroPace Inc | NPCE | Kumar Rakhi Director |
21,698 | $0 | 21,698 (Direct) |
View |
| 2021-04-21 Option Award |
2021-10-08 6:13 pm |
N/A 2031-04-20 |
NeuroPace Inc | NPCE | LACOB JOSEPH Director |
21,698 | $0 | 21,698 (Direct) |
View |
| 2021-06-04 Option Award(A) |
2021-06-29 6:12 pm |
2021-06-04 2031-06-03 |
NeuroPace Inc | NPCE | Favet Michael Chief Executive Officer |
81,000 | $0 | 81,000 (Direct) |
View |
| 2021-06-04 Option Award(A) |
2021-06-29 6:12 pm |
2021-06-04 2031-06-03 |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical officer |
24,930 | $0 | 26,448 (Direct) |
View |
| 2021-06-04 Option Award(A) |
2021-06-29 6:11 pm |
2021-06-04 2031-06-03 |
NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer |
24,930 | $0 | 28,156 (Direct) |
View |
| 2021-06-04 Option Award(A) |
2021-06-29 6:09 pm |
2021-06-04 2031-06-03 |
NeuroPace Inc | NPCE | Ridley Irina General Counsel and Secretary |
17,310 | $0 | 19,662 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 6:05 pm |
2021-06-04 2031-06-03 |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical officer |
24,544 | $0 | 26,062 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 6:04 pm |
2021-06-04 2031-06-03 |
NeuroPace Inc | NPCE | Favet Michael Chief Executive Officer |
79,770 | $0 | 102,717 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 6:03 pm |
2021-06-04 2031-06-03 |
NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer |
24,544 | $0 | 27,770 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 6:02 pm |
2021-06-04 2031-06-03 |
NeuroPace Inc | NPCE | Ridley Irina General Counsel and Secretary |
17,044 | $0 | 19,396 (Direct) |
View |
| 2021-04-26 Conversion |
2021-04-26 5:21 pm |
N/A N/A |
NeuroPace Inc | NPCE | Fischer Frank M Director |
944,732 | $0 | 565,657 (Direct) |
View |
| 2021-04-26 Conversion |
2021-04-26 5:20 pm |
N/A N/A |
NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
7,554,562 | $0 | 4,012,281 (Indirect) |
View |
| 2021-04-26 Conversion |
2021-04-26 5:18 pm |
N/A N/A |
NeuroPace Inc | NPCE | Norton Evan Director |
3,454,422 | $0 | 4,042,657 (Indirect) |
View |
| 2021-04-26 Conversion |
2021-04-26 5:18 pm |
N/A N/A |
NeuroPace Inc | NPCE | Accelmed Partners II L.P. 10% Owner |
3,454,422 | $0 | 7,497,079 (Direct) |
View |
| 2021-04-26 Conversion |
2021-04-26 5:17 pm |
N/A N/A |
NeuroPace Inc | NPCE | Garfield Greg Shaw Director |
11,228,768 | $0 | 5,614,384 (Indirect) |
View |
| 2021-04-26 Option Award |
2021-04-26 5:16 pm |
N/A N/A |
NeuroPace Inc | NPCE | Favet Michael Chief Executive Officer |
15,385 | $0.03 | 22,947 (Indirect) |
View |
| 2021-04-26 Conversion |
2021-04-26 5:16 pm |
N/A N/A |
NeuroPace Inc | NPCE | Favet Michael Chief Executive Officer |
15,124 | $0 | 22,947 (Indirect) |
View |
| 2021-04-26 Option Award |
2021-04-26 5:15 pm |
N/A N/A |
NeuroPace Inc | NPCE | LACOB JOSEPH Director |
334,027 | $0 | 351,920 (Indirect) |
View |
| 2021-04-26 Conversion |
2021-04-26 5:15 pm |
N/A N/A |
NeuroPace Inc | NPCE | LACOB JOSEPH Director |
334,027 | $0 | 351,920 (Indirect) |
View |
| 2021-04-26 Conversion |
2021-04-26 5:14 pm |
N/A N/A |
NeuroPace Inc | NPCE | KCK LTD. 10% Owner |
11,190,986 | $0 | 5,621,111 (Direct) |
View |
| 2021-04-21 Option Award |
2021-04-23 7:43 pm |
N/A 2031-04-20 |
NeuroPace Inc | NPCE | Fischer Frank M Director |
21,698 | $0 | 114,989 (Direct) |
View |
| 2021-04-21 Option Award |
2021-04-23 7:27 pm |
N/A 2031-04-20 |
NeuroPace Inc | NPCE | Garfield Greg Shaw Director |
21,698 | $0 | 60,551 (Direct) |
View |
Ownership |
2021-04-20 5:34 pm |
N/A N/A |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical officer |
0 | $0 | 293,942 (Direct) |
View |